Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib in the Blood
Sponsor: Boehringer Ingelheim
Summary
The main objective of this trial is to investigate the effect of carbamazepine, a strong CYP3A4 inducer on the pharmacokinetics of verducatib at steady state.
Official title: An Open-label, Fixed-sequence, Two-period Phase I Trial to Evaluate the Effect of Multiple Oral Doses of Carbamazepine, a Strong CYP3A4 Inducer, on the Pharmacokinetics of Verducatib at Steady State in Healthy Male Trial Participants
Key Details
Gender
MALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2026-09-10
Completion Date
2026-12-20
Last Updated
2026-09-23
Healthy Volunteers
Yes
Conditions
Interventions
Verducatib
Verducatib
Carbamazepine
Carbamazepine
Locations (1)
CRS Clinical Research Services Berlin GmbH
Berlin, Germany